| Outcome Measures: |
Primary: Glycemic Variability (mean amplitude of glycemic excursion), MAGE(mean amplitude of glycemic excursion), baseline and 12 weeks|Glycemic Variability (Coefficient of Variation), CV (Coefficient of Variation), baseline and 12 weeks|Glycemic Variability (Standard Deviation), SD (Standard Deviation), baseline and 12 weeks | Secondary: glycemic control variables HbA1C, HbA1C, baseline and each visit(6weeks, 12weeks)|glycemic control variables Fasting Plasma Glucose, Fasting Plasma Glucose, baseline and each visit(6weeks, 12weeks)|lipid profile Total cholesterol, Total cholesterol, baseline and each visit(6weeks, 12weeks)|lipid profile Triglyceride, Triglyceride, baseline and each visit(6weeks, 12weeks)|lipid profile HDL-cholesterol, HDL-cholesterol, baseline and each visit(6weeks, 12weeks)|lipid profile LDL-cholesterol, LDL-cholesterol, baseline and each visit(6weeks, 12weeks)|glycemic control variables Percentage of patients achieving HbA1c < 7%, Percentage of patients achieving HbA1c \< 7%, 12weeks|glycemic control variables Percentage of patients achieving HbA1c < 6.5%, Percentage of patients achieving HbA1c \< 6.5%, 12weeks|glycemic control variables 24hr urinary glucose excretion, 24hr urinary glucose excretion, baseline and 12weeks|glycemic control variables Changes in insulin dose, Changes in insulin dose, baseline and each visit(6weeks, 12weeks)|blood pressure SBP, SBP, baseline and each visit(6weeks, 12weeks)|blood pressure DBP, DBP, baseline and each visit(6weeks, 12weeks)
|
